Management of Ulcerative Colitis Symptoms

Tromphia, also known as Gesalcomab, is a prescription medication designed to assist adults with moderately to severely active ulcerative colitis in managing their symptoms. Clinical trials have shown that many patients have achieved significant clinical remission after one year of treatment, with some even reaching endoscopic remission. However, individual responses to Tromphia can vary, highlighting the necessity for personalized medical assessment before commencing treatment. Patients considering this medication should discuss potential risks, such as serious allergic reactions and increased susceptibility to infections, with their healthcare providers.